Compare to the live page

November

November 12, 2025

Update on standing committee motion – disaggregated data request

Dear colleagues,

I'm writing to share an update on the Standing Committee on Science and Research's

October 1 motion

requesting that the federal granting agencies submit a large volume of disaggregated data related to tri-agency-funded research and researchers. This initial motion called for the agencies to submit individualized EDI data, application details, peer review scores and notes and information on both successful and unsuccessful applicants.

While CIHR already discloses key details about funded applications, such as applicant names, affiliations, project summaries and funding amounts, the breadth of the motion raised concerns across the research community, culminating in

a letter-writing campaign

that garnered more than 5,000 signatures.

Amended motion

On November 5, the standing committee amended its motion, requesting only aggregated, anonymized data.

This amendment provides reassurance that the funding agencies' obligations under the

Privacy Act

and our commitment to safeguarding researchers' information and the integrity of the peer review process were understood by the committee.

What the funding agencies did release

By the committee's deadline of November 4 for its original motion, we provided details on funded applications that are already disclosed online—including researcher names, afiliations, project summaries and funding amounts—and aggregated EDI data for funded and unfunded applications

so that individuals cannot be identified.

Please do not hesitate to reach out with any questions. I want to thank each and every one of you for your services to peer review and your dedication to the health research enterprise.

Sincerely,

Adrian Mota,

Acting Vice-President, Research – Programs

Canadian Institutes of Health Research

October

October 8, 2025

In Memoriam – Dr. Balfour Mount

It is with profound sadness that we learn of the passing of Dr. Balfour Mount.

Widely regarded as the father of end-of-life care, Dr. Mount began his medical career as a urologist and a surgical oncologist. Beginning in the 1970s, Dr. Mount became interested in the needs of the terminally ill and their families, and began travelling around the world to explain and promote palliative care – a term he coined. In both his research and medical practice, he combined scientific excellence with deep compassion and an abiding appreciation for the importance of alleviating suffering.

A medical graduate of Queen's University, his work earned him many accolades, including the American Academy of Hospice and Palliative Medicine Humanities Award (2013), the Queen Elizabeth II Diamond Jubilee Medal (2012), Officer of the Order of Canada (2004), and Officer of the Order of Quebec (1988).

All of us at CIHR express our deep gratitude for Dr. Mount's pioneering contributions to health care, and offer our sincere condolences to his family and friends.

May

May 2, 2025

In Memoriam – Dr. Henry Friesen